Name: Dr. Praveen Kandi
Educational Qualification: Ph.D.
Designation: Associate Director, CMC- Formulation Development
Department: Department of Pharmaceutical Sciences
University: Karuna Therapeutics Inc. Boston, MA
Email: Praveenkandi@gmail.com
Research Interests: Pharmaceutical medicine/drug development, Formulation, CMC, drug delivery (Cocrystals, Nano & Microparticles, Lymphatic Drug Delivery, Solid & Liquid Orals), New & generic drug development (NDA, ANDA)], Specializing in Behavioral & Neuropharmacology (Brain Drug Delivery, neuropsychiatric disorders (Depression, Schizophrenia) and Anticancer Therapeutics.
Biography: Dr. Praveen Kandi is currently working as Associate director, CMC- formulation development at karuna Therapeutics Inc. Dr. Kandi is a passionate, accomplished and well recognized expert and leader in drug development for numerous generic ANDA’s and several NDA’s from early stage product and process development to late stage validation/ communalization for numerous debilitating ailments in CNS disorders , Epilepsy, Cancer, etc. Also currently holds master degree in molecular genetics and biochemistry from Georgia State University and a PHD in Pharmaceutical sciences drug delivery to the brain from Mercer University, Atlanta.
UNIVERSITY and COMMUNITY SERVICE
Graduate Students Mentor, Mercer Uni., Atlanta, GA (Research techn. & exp. design) 2008 – 2012
Vice Chair for GRASP (Graduate Research Association of Students in Pharmacy) conference, June 2009, Mercer University, Atlanta, GA 2008 – 2009
Vice President MISO (Mercer International Student Organization), Mercer University, GA 2007 – 2012
Webmaster for MUSCA (Mercer University Student Chapter of AAPS), GA 2007 – 2011
Charity Organizations for Children - VIBHA- Atlanta, AID-Atlanta, Feed The Children 2005 – Present
Student Representative, RGUHS, Bangalore, KA, India 2000 – 2001
MEMBERSHIPS and SERVICES
CMC (Chemistry Manufacturing and Controls Community) Member Engagement Manager, American Association for Pharmaceutical Scientists (AAPS), 2020 – Present
MRC (Modified Release Community) Member Engagement Manager, American Association for Pharmaceutical Scientists (AAPS), 2020 – Present
Editorial Board Member, United Journal of Drug Development and Industrial Pharmacy *, September 2020 – Present
Editorial Board Member, ACTA Scientific *, Nov 2014 – Present
Associate Editorial Board Member, Bioequivalence & Bioavailability (MOJBB), MedCrave Journals*, November 2015– Present
Editorial Board Member, Journal of Pharmacy and Pharmaceutical Sciences, Bio Accent (BAOJ Pharmaceutical Sciences) *, November 2014 – Present
Conference Abstract Reviewer, AAPS Annual Meeting Abstracts, FDD Section, ** 2008 – Present
Conference Abstract Reviewer, AAPS National Biotechnology Conference (NBC), ** 2009 – Present
Member, American Association for Pharmaceutical Scientists (AAPS), 2007 – Present
Member, Controlled Release Society (CRS), 2007 – Present
Member, NANOFANS, Georgia Institute of Technology, GA 2007 – Present
Serial no: